This statistic depicts the cancer specialist input into MCO (managed care organization) coverage policy development in the United States, as of 2018. Some 20 percent of MCOs stated they have direct oncology specialist input in survivorship planning care.
Cancer specialist input into MCO coverage policy development in the United States as of 2018
Specialist input
Percentage of respondents
Genetic testing and counseling in oncology
62%
Molecular/biomarker testing in oncology (Pathologists input)
58%
Molecular/biomarker testing in oncology (Oncologists input)
57%
Next-generation sequencing in oncology
44%
Advance care planning and palliative care
39%
Survivorship planning care
20%
Created with Highcharts 7.2.2Specialist inputPercentage of respondents62%62%58%58%57%57%44%44%39%39%20%20%Genetic testing and counseling in oncologyMolecular/biomarker testing in oncology (Pathologists input)Molecular/biomarker testing in oncology (Oncologists input)Next-generation sequencing in oncologyAdvance care planning and palliative careSurvivorship planning care
0%5%10%15%20%25%30%35%40%45%50%55%60%65%70%
Add this content to your personal favorites. These can be accessed from the favorites menu in the main navigation.
You have no right to use this feature.
Make sure to contact us if you are interested in scientific citation.
You can upgrade your account to enable this functionality for all statistics.
This feature is not available with your current account.Request access
The survey in total includes data from following groups: managed care organizations (MCOs), specialty pharmacies (SPs), oncologists, oncology practice managers (OPMs), employers that sponsor health benefits.
Statista has been my savior on several occasions.
The site is easy to maneuver and the data is in a format that can
go right into a report or presentation.
Learn more about how Statista can support your business.
Genentech. (May 7, 2019). Cancer specialist input into MCO coverage policy development in the United States as of 2018 [Graph]. In Statista. Retrieved February 26, 2025, from https://www.statista.com/statistics/544270/cancer-specialist-input-in-mco-coverage-policy-in-us/
Genentech. "Cancer specialist input into MCO coverage policy development in the United States as of 2018." Chart. May 7, 2019. Statista. Accessed February 26, 2025. https://www.statista.com/statistics/544270/cancer-specialist-input-in-mco-coverage-policy-in-us/
Genentech. (2019). Cancer specialist input into MCO coverage policy development in the United States as of 2018. Statista. Statista Inc.. Accessed: February 26, 2025. https://www.statista.com/statistics/544270/cancer-specialist-input-in-mco-coverage-policy-in-us/
Genentech. "Cancer Specialist Input into Mco Coverage Policy Development in The United States as of 2018." Statista, Statista Inc., 7 May 2019, https://www.statista.com/statistics/544270/cancer-specialist-input-in-mco-coverage-policy-in-us/
Genentech, Cancer specialist input into MCO coverage policy development in the United States as of 2018 Statista, https://www.statista.com/statistics/544270/cancer-specialist-input-in-mco-coverage-policy-in-us/ (last visited February 26, 2025)
Cancer specialist input into MCO coverage policy development in the United States as of 2018 [Graph], Genentech, May 7, 2019. [Online]. Available: https://www.statista.com/statistics/544270/cancer-specialist-input-in-mco-coverage-policy-in-us/
Profit from additional features with an Employee Account
Please create an employee account to be able to mark statistics as favorites.
Then you can access your favorite statistics via the star in the header.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.